Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received a grant of 2,776.7700 phantom stock units on Zoetis common stock, valued at $39.6400 per unit. These units were acquired under the Zoetis Supplemental Savings Plan as a compensation-related award.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s value. The units are settled in cash after her separation from service, and their value is tied to Zoetis’s share price and the associated cash-equivalent investments.
Following this grant, Peck holds a total of 65,578.8067 phantom stock units directly under the plan. The filing does not reflect an open-market stock purchase or sale, but rather a non-market, cash-settled compensation award linked to Zoetis’s stock performance.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 26.1975 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. This compensation award increases her total phantom stock unit balance to 6,035.7462 units, whose value is tied to Zoetis common stock plus a small cash-equivalent component.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Financial Officer Joseph Wetteny received a grant of 873.9476 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component.
The units are cash-settled after his separation from service rather than delivering actual shares. Following this award, Wetteny holds a total of 9,792.3028 phantom stock units, notionally referencing 293.9359 shares of Zoetis common stock. This filing reflects routine compensation, not an open-market stock purchase or sale.
Zoetis Inc. Executive Vice President Keith Sarbaugh received a grant of phantom stock units as compensation. On this date, he acquired 230.7598 phantom stock units at a reference value of $39.64 per unit, bringing his total phantom stock unit balance to 2105.1927. Each phantom stock unit tracks the value of Zoetis common stock plus a small portion of cash-equivalent investments, and will be settled in cash after his separation from service.
Zoetis Inc. is asking shareholders to vote at its virtual 2026 Annual Meeting on May 20, 2026, covering director elections, executive pay and other key items. Shareholders will elect twelve directors for one-year terms, cast an advisory vote on executive compensation and choose the future frequency of say-on-pay votes.
They will also vote on ratifying KPMG LLP as independent auditor for 2026 and on a shareholder proposal to permit action by written consent, which the Board recommends voting against. The proxy describes Zoetis’ 2025 performance, including 6% organic operational revenue growth and 7% organic operational adjusted net income growth, as well as extensive board independence, skills and sustainability oversight.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity involving restricted stock units. On March 31, 2026, 1,528.0167 restricted stock units vested and were settled into 1,528 shares of Zoetis common stock, reflecting an exercise or conversion of derivative securities.
To cover tax obligations related to this vesting, 524 common shares were withheld at a price of $118.21 per share, classified as a tax-withholding disposition rather than an open-market sale. After these transactions, Sarbaugh directly held 3,346 shares of Zoetis common stock, along with remaining restricted stock units representing 2,674, 773 and 120 underlying common shares that will vest over future anniversaries if service conditions are met.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller received a grant of 669.3367 Phantom Stock Units tied to Zoetis common stock. These units were awarded at a reference value of $38.2000 per unit under the Zoetis Supplemental Savings Plan and are settled in cash after she leaves the company.
Following this award, Fuller holds a total of 1247.3931 Phantom Stock Units. Each unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of each unit’s value, so the unit value tracks the Zoetis share price and these cash-equivalent holdings.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny received a grant of 2,114.7557 phantom stock units on Zoetis common stock. The award was made at a reference value of $38.20 per unit under the Zoetis Supplemental Savings Plan.
Following this grant, Wetteny holds a total of 8,918.3552 phantom stock units. Each phantom stock unit tracks the market value of Zoetis common stock plus a small portion of cash-equivalent investments, and is settled in cash after his separation from service. The award currently corresponds to 712.6923 underlying shares of Zoetis common stock.
Zoetis Inc. Chief Executive Officer Kristin C. Peck received a grant of 4,391.2607 Phantom Stock Units at a reference price of $38.20 per unit. Following this award, she holds a total of 62,802.0367 Phantom Stock Units.
Each Phantom Stock Unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of the unit’s total value. These units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after her separation from service.